These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10506875)

  • 41. Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC values.
    Jones RN; Fritsche TR; Sader HS; Stilwell MG
    Diagn Microbiol Infect Dis; 2007 May; 58(1):9-17. PubMed ID: 17408903
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Resistance surveillance of common community respiratory pathogens isolated in China, 2002 - 2003].
    Wang H; Yu YS; Liu Y; Li HY; Hu BJ; Sun ZY; Chen MJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Mar; 27(3):155-60. PubMed ID: 15130324
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000].
    Melo-Cristino J; Fernandes ML; Serrano N;
    Acta Med Port; 2001; 14(5-6):459-68. PubMed ID: 11878155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Pseudomonas aeruginosa isolated in major hospitals in Nagano prefecture].
    Hachiya T; Kubo K; Yanagisawa H
    Jpn J Antibiot; 2004 Apr; 57(2):157-71. PubMed ID: 15219055
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
    Jones RN; Sader HS; Stilwell MG; Fritsche TR
    Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Recent trends in incidence of respiratory tract pathogens and antimicrobial susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis isolated in 1994 and 1995].
    Nishioka K; Ogihara H; Ohno I; Shirato K
    Jpn J Antibiot; 1997 Sep; 50(9):768-75. PubMed ID: 9394237
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bacterial findings in acute maxillary sinusitis--European study.
    Penttilä M; Savolainen S; Kiukaanniemi H; Forsblom B; Jousimies-Somer H
    Acta Otolaryngol Suppl; 1997; 529():165-8. PubMed ID: 9288300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
    Harrison CJ; Woods C; Stout G; Martin B; Selvarangan R
    J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1998)].
    Ikemoto H; Arakawa M; Gejyo F; Igarashi K; Mori T; Okada M; Ozaki K; Igari J; Aoki N; Oguri T; Kitamura N; Terai T; Sekine O; Suzuki Y; Inoue H; Nakadate T; Karasawa Y; Ito C; Yoshida T; Nakata K; Nakatani T; Ohno I; Okada S; Inagawa H; Kudo K; Kobayashi N; Ando M; Suga M; Sato K; Kondo T; Tosaka M; Kobayashi H; Kawai S; Takayasu S; Kohno S; Tomono K; Shimada K; Nakano K; Miyazaki Y; Izumikawa K; Yamaguchi T; Mochida C; Yokouchi H; Ito A; Sumitomo M; Nasu M; Nagai H; Yamasaki T; Matsushima T; Nakano T
    Jpn J Antibiot; 2000 May; 53(5):261-98. PubMed ID: 10923284
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changing antimicrobial susceptibility patterns among Streptococcus pneumoniae and Haemophilus influenzae from Brazil: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Castanheira M; Gales AC; Pignatari AC; Jones RN; Sader HS
    Microb Drug Resist; 2006; 12(2):91-8. PubMed ID: 16922623
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differences in nasopharyngeal bacterial carriage in preschool children from different socio-economic origins.
    Jourdain S; Smeesters PR; Denis O; Dramaix M; Sputael V; Malaviolle X; Van Melderen L; Vergison A
    Clin Microbiol Infect; 2011 Jun; 17(6):907-14. PubMed ID: 20977542
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Antimicrobial susceptibility of Streptococcus pneumoniae and Haemophilus influenzae isolated in major hospitals in Nagano Prefecture].
    Yamazaki Y; Yagi H; Kubo K; Morita M; Hirayama J; Hayasaka M; Harada K; Honda T; Hirai K; Yanagisawa H
    Jpn J Antibiot; 2002 Oct; 55(5):524-36. PubMed ID: 12532636
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.
    White AR; Kaye C; Poupard J; Pypstra R; Woodnutt G; Wynne B
    J Antimicrob Chemother; 2004 Jan; 53 Suppl 1():i3-20. PubMed ID: 14726431
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hemophilus influenzae bronchitis and pneumonia.
    Gleckman R; Hibert D
    Am Fam Physician; 1982 Nov; 26(5):153-7. PubMed ID: 6983289
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
    Hsueh PR; Huang WK; Shyr JM; Lau YJ; Liu YC; Luh KT
    J Formos Med Assoc; 2004 Sep; 103(9):664-70. PubMed ID: 15361938
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Cefditoren and community-acquired lower respiratory tract infections (corrected)].
    Barberán J; Mensa J
    Rev Esp Quimioter; 2009 Sep; 22(3):144-50. PubMed ID: 19662548
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden.
    Kallings I; Bengtsson S; Christensen P; Holm SE; Lind L; Kalin M
    Scand J Infect Dis Suppl; 1983; 39():100-5. PubMed ID: 6359377
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2003)].
    Goto H; Takeda H; Kawai S; Nakadate T; Shimada K; Nakano K; Suwabe A; Yokouchi H; Okada S; Ashino Y; Ikemoto H; Gejyo F; Igari J; Okada M; Oguri T; Aoki N; Mori T; Yamamoto M; Kitamura N; Inoue H; Suzuki Y; Karasawa Y; Tosaka M; Kudo K; Kobayashi N; Kohno S; Tanaka T; Hirakata Y; Kondo A; Matsuda J; Nakano M; Sumitomo M; Nasu M; Niki Y; Hiramatsu K; Suga M; Suzuki Y
    Jpn J Antibiot; 2005 Jun; 58(3):326-58. PubMed ID: 16161758
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bacterial resistance in the new millennium. Its impact on antibiotic selection for respiratory tract infections.
    Appelbaum PC
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):5-16. PubMed ID: 19667544
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Staphylococcus aureus is a major pathogen in acute bacterial rhinosinusitis: a meta-analysis.
    Payne SC; Benninger MS
    Clin Infect Dis; 2007 Nov; 45(10):e121-7. PubMed ID: 17968816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.